For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover, develop and deliver innovative medicines that help patients prevail over ... of the Squibb logo was designed.

In a report released on November 8, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a price target of $43.00. The company’s shares closed ...

RBC Capital analyst Leonid Timashev maintained a Hold rating on Design Therapeutics (DSGN – Research Report) yesterday and set a price ...

The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.

The Gift Nifty futures were trading at 23,622 as of 08:18 a.m. IST, indicating that the benchmark Nifty 50 will open slightly ...

Dyne Therapeutics Inc. 4.27% $2.94B ...

Sanofi S.A. Part Cert 0.06% €8.19M ...

After hours: November 13 at 4:47 PM EST Loading Chart for PSTV ...

Chief Justice Ivor Archie should let good sense prevail and allow the police to keep their firearms. As matters stand, the Judiciary has failed to present a convincing case for its present policy.

The CVR pays out if one of Prevail’s gene therapies is approved in one of several developed countries before December 31, 2024. Lilly pays up to $1.04bn for neurology gene therapy biotech ...